National Institutes of Health: all 11,571 studies

Page 104 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic TherapyCompletedNCT00001807
• Methods in Education for Breast Cancer GeneticsCompletedNCT00001806Phase 3
• A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabCompletedNCT00001805Phase 2
• Von Hippel-Lindau Disease Genetic Epidemiology StudyTerminatedNCT00001803
• Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe PsoriasisCompletedNCT00001797Phase 2
• Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and NeutropeniaCompletedNCT00001790Phase 1
• BG9588 (Anti-CD40L Antibody) to Treat Lupus NephritisCompletedNCT00001789Phase 2
• Genetic Basis of Primary ImmunodeficienciesTerminatedNCT00001788
• Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)CompletedNCT00001785Phase 2
• Mexiletine for the Treatment of Focal DystoniaCompletedNCT00001784Phase 2
• Motor Recovery in Recent Stroke Patients Treated With Amphetamine and Physical TherapyCompletedNCT00001783Phase 2
• Areas of Brain Responsible for Understanding American Sign LanguageCompletedNCT00001782
• Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS)CompletedNCT00001781Phase 2
• Magnetic Stimulation of the Human Nervous SystemCompletedNCT00001780
• Sertraline for the Treatment of Patients With Frontal Lobe Dementia (FLD)CompletedNCT00001777Phase 1
• Effects of Brain Stimulation on Learning and ReasoningCompletedNCT00001776
• Vasodilation in Patients With Fabry's DiseaseCompletedNCT00001774
• Evaluation of Patients With Rapid Cycling Bipolar Disorder (RCBD)CompletedNCT00001772
• I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal VolunteersCompletedNCT00001771
• Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)CompletedNCT00001770
• Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)CompletedNCT00001768Phase 3
• Drug Interactions Among Anti-HIV AgentsCompletedNCT00001766Phase 1
• Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous DiseaseCompletedNCT00001765Phase 1
• Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory ConditionsCompletedNCT00001764Phase 1
• Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex InfectionCompletedNCT00001763Phase 1
• Magnetic Resonance Imaging of the Face and BonesCompletedNCT00001762
• Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's GranulomatosisCompletedNCT00001761Phase 1
• Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy IndividualsCompletedNCT00001760
• Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission TomographyCompletedNCT00001759
• Continued Antiretroviral Therapy With Abacavir, Amprenavir and EfavirenzCompletedNCT00001758Phase 2
• An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsCompletedNCT00001757Phase 3
• Study of Mast Cell PrecursorsCompletedNCT00001756
• Study of Skeletal Disorders and Short StatureCompletedNCT00001754
• Study of the Effects of Temperature on Metabolism in Human MuscleCompletedNCT00001753Phase 1
• Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal WomenCompletedNCT00001752Phase 2
• Comparing Treatments for Multiple MyelomaCompletedNCT00001750Phase 2
• Medical Treatment for Diamond Blackfan AnemiaCompletedNCT00001749Phase 2
• HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological MalignanciesCompletedNCT00001748Phase 1
• Racial Differences in Control of Blood Vessel Tone and Blood FlowCompletedNCT00001747
• Screening for Inherited Heart DiseaseCompletedNCT00001746
• The Role of Cyclooxygenase Activity in the Endothelial Function of Hypertensive and Hypercholesterolemic PatientsCompletedNCT00001742
• Study of Inherited Changes of Receptors Located on Blood VesselsCompletedNCT00001741Phase 1
• Evaluation of Left Ventricular Volumes by Real-Time 3-Dimensional EchocardiographyCompletedNCT00001740
• Vascular Endothelial Growth Factor (VEGF) in UveitisCompletedNCT00001738
• Cyclosporin Implant to Treat UveitisCompletedNCT00001737Phase 1
• New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in CystinosisCompletedNCT00001736Phase 1
• Gene Therapy for Gyrate AtrophyCompletedNCT00001735Phase 1
• Screening for NEI Clinical StudiesCompletedNCT00001734
• Screening for Studies on Retinovascular DiseasesCompletedNCT00001733
• Screening for Studies on Inherited Eye DiseasesCompletedNCT00001732
• Treatment of Dry Eye Syndrome With Cyclosporin A Eye DropsCompletedNCT00001731Phase 2
• Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.CompletedNCT00001730Phase 4
• Combination Drug Therapy for Patients With Hepatitis CCompletedNCT00001729Phase 3
• Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright SyndromeCompletedNCT00001728Phase 2
• Study of the Composition of Dental PlaqueCompletedNCT00001726
• Studies of Dextromethorphan and Topiramate to Treat Oral and Facial PainCompletedNCT00001725Phase 2
• Local Flurbiprofen to Treat Pain Following Wisdom Tooth ExtractionCompletedNCT00001724Phase 2
• Fat Tissue Microperfusion to Measure Leptin Secretion and Its Relations With Fat Breakdown in HumansCompletedNCT00001722
• Study of Smith-Lemli-Opitz SyndromeCompletedNCT00001721
• Treatment of Childhood Osteoporosis With Alendronate (Fosamax)CompletedNCT00001720Phase 2
• Magnetic Resonance Imaging of Blood Flow in the Liver and AbdomenCompletedNCT00001719
• Facilitation of Oral Bolus Propulsion Using Electropalatography in Patients With DysphagiaCompletedNCT00001718Not applicable
• Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed ConsentCompletedNCT00001717
• Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell AnemiaCompletedNCT00001716Phase 2
• Evaluation of Patients With Blood DisordersCompletedNCT00001715
• Magnetization Transfer Quantitation and Characterization for Clinical ScannersCompletedNCT00001714
• Treatment for Blood Clots in the Veins of the LegsCompletedNCT00001713Phase 1
• Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in JapanCompletedNCT00001712
• Magnetic Resonance Imaging (MRI) Ofl VolunteersCompletedNCT00001711
• Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal SequenceCompletedNCT00001705Phase 2
• Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis InfectionCompletedNCT00001702
• Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans InfectionCompletedNCT00001701
• A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their MothersCompletedNCT00001699
• Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCRCompletedNCT00001698Phase 2
• A Pharmacokinetic Study of Genistein, a Tyrosine Kinase InhibitorCompletedNCT00001696Phase 1
• Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical TrialsCompletedNCT00001695
• Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and CarriersCompletedNCT00001693Phase 1
• A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With LeukemiaCompletedNCT00001689Phase 1
• A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and StavudineCompletedNCT00001688Phase 2
• Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare DiseasesCompletedNCT00001686
• Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and TyrosinaseCompletedNCT00001685Phase 2
• A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic CancerCompletedNCT00001683Phase 1
• A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus ConcentrationsCompletedNCT00001681
• A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus ErythematosusCompletedNCT00001680Phase 2
• Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis PatientsCompletedNCT00001679
• Genetics of Rheumatoid ArthritisCompletedNCT00001678
• Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and EfficacyCompletedNCT00001677Phase 2
• Cyclophosphamide and Fludarabine to Treat Lupus NephritisCompletedNCT00001676Phase 1
• The Effect of Positive and Negative Emotions on Brain Activity in Alcoholics and NonalcoholicsCompletedNCT00001675
• Screening Evaluation for Studies of the National Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedNCT00001673
• Language Localization Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With EpilepsyCompletedNCT00001672
• The Classification and Cause of Leukodystrophies of Unknown CauseCompletedNCT00001671
• A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) PatientsCompletedNCT00001669Phase 2
• Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac TumorsCompletedNCT00001668
• Genotype/Phenotype Correlation of Movement Disorders and Other Neurological DiseasesCompletedNCT00001667
• Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial EpilepsyCompletedNCT00001666
• Transcranial Magnetic Stimulation for the Treatment of Parkinson's DiseaseCompletedNCT00001665
• Sleep Disorders of Patients With Diseases of the Nervous SystemCompletedNCT00001664
• Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic StimulationCompletedNCT00001663Phase 1
• Treatment of Alzheimer's Disease With CX516 (Ampalex)CompletedNCT00001662Phase 2

← National Institutes of Health overview and focus areas